Yadav Dharmendra Kumar, Kumar Surendra, Choi Eun-Ha, Chaudhary Sandeep, Kim Mi-Hyun
Gachon Institute of Pharmaceutical Science & Department of Pharmacy, College of Pharmacy, Gachon University, Incheon, South Korea.
Plasma Bioscience Research Center/PDP Research Center, Kwangwoon University, Nowon-Gu, South Korea.
Front Chem. 2020 Apr 15;8:250. doi: 10.3389/fchem.2020.00250. eCollection 2020.
Aquaporin-3 (AQP3) is one of the aquaglyceroporins, which is expressed in the basolateral layer of the skin membrane. Studies have reported that human skin squamous cell carcinoma overexpresses AQP3 and inhibition of its function may alleviate skin tumorigenesis. In the present study, we have applied a virtual screening method that encompasses filters for physicochemical properties and molecular docking to select potential hit compounds that bind to the Aquaporin-3 protein. Based on molecular docking results, the top 20 hit compounds were analyzed for stability in the binding pocket using unconstrained molecular dynamics simulations and further evaluated for binding free energy. Furthermore, examined the ligand-unbinding pathway of the inhibitor from its bound form to explore possible routes for inhibitor approach to the ligand-binding site. With a good docking score, stability in the binding pocket, and free energy of binding, these hit compounds can be developed as Aquaporin-3 inhibitors in the near future.
水通道蛋白3(AQP3)是水甘油通道蛋白之一,表达于皮肤膜的基底外侧层。研究报道,人类皮肤鳞状细胞癌中AQP3过表达,抑制其功能可能减轻皮肤肿瘤发生。在本研究中,我们应用了一种虚拟筛选方法,该方法包括物理化学性质筛选和分子对接,以选择与水通道蛋白3蛋白结合的潜在命中化合物。基于分子对接结果,使用无约束分子动力学模拟分析了前20个命中化合物在结合口袋中的稳定性,并进一步评估了结合自由能。此外,研究了抑制剂从结合形式的配体解离途径,以探索抑制剂接近配体结合位点的可能途径。凭借良好的对接分数、在结合口袋中的稳定性和结合自由能,这些命中化合物在不久的将来可被开发为水通道蛋白3抑制剂。